October 9, 2008 - Lumen Biomedical Inc. said today the FDA cleared the LBI Embolectomy System for use in the removal of fresh, soft emboli and thrombi from vessels in the peripheral vasculature.

October 9, 2008 - A report on initial clinical experiences with Prescient Medical’s vProtect Luminal Shield in patients with non–flow-limiting “vulnerable” plaques will be presented at TCT 2008.

Professor Patrick Serruys, director of clinical research and chief of interventional cardiology at the Erasmus Medical Center in Rotterdam, the Netherlands, will present early findings and describe the rationale and design of the SECRITT I trial, a randomized pilot study of the device in patients with vulnerable plaque.

October 8, 2008 – FDA informed healthcare professionals this week it reviewed preliminary data from UPLIFT (Understanding the Potential Long-Term Impacts on Function with Tiotropium) reported by Boehringer Ingelheim, which showed no increased risk of stroke with tiotropium bromide compared to placebo.

October 8, 2008 - St. Jude Medical Inc. today celebrates the 50th anniversary of the world’s first implantable pacemaker.

Oct. 8, 1958, a Swedish man named Arne Larsson received the world’s first implanted pacemaker. The groundbreaking technology for the implantable cardiac pacemaker was developed by Rune Elmqvist, M.D., of the Swedish company Elema Schönander, which eventually became part of St. Jude Medical.

October 8, 2008 - SurModics Inc. today said the PROTEX Coronary Stent System incorporating SurModics’ proprietary Finale prohealing coating technology was used in the first-in-human trial evaluating the safety of the device for the treatment of coronary artery disease.

October 8, 2008 - Ivivi Technologies Inc. said yesterday the FDA reopened the submission for an additional round of review for its SofPulse M-10, Roma and Torino II targeted pulsed electromagnetic field (tPEMF) products 510(k) submission, in response to the company’s appeal of the FDA’s earlier “not substantially equivalent” (NSE) decision.

October 8, 2008 - CryoLife Inc. announced yesterday that cardiovascular surgeons from around the world will join the Ross Summit 2008, a two-day surgical congress to be held at the Company's corporate headquarters training facility in Kennesaw, GA, Oct. 10 and 11.

October 8, 2008 – Medical imaging company Barco has introduced a new version of its Voxar 3D advanced visualization product that integrates seamlessly into FUJIFILM’s Synapse PACS platform.

The new integration allows Synapse users to read their studies faster without major infrastructure investment and provides a five-fold increase in image loading performance, according to Barco.

The Mynx Vascular Closure Device (VCD) by AccessClosure Inc. closes arterial puncture sites during cardiac catheterization procedures and is designed to minimize the pain historically associated with other closure devices.

The Mynx uses an extravascular, conformable, sponge-like material to seal the puncture site. The sealant material is called polyethylene glycol (PEG) and has been used safely for more than a decade in a wide range of medical products. the company said.

For catheterization labs performing both cardiac and vascular interventions, Philips Healthcare will highlight clinical tools like Allura 3D Coronary Angiography and StentBoost, as well as several new Allura Xper FD 20 features including a larger, tableside module with the ability to download images or runs to a USB stick.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now